NCT06813807View on ClinicalTrials.gov

A Comparative Study of the Pharmacokinetic Profiles of Timolol Maleate Ophthalmic Gel With Timolol Maleate Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

July 5, 2024

Study Completion Date

July 5, 2024

Conditions
Healthy Subjects
Interventions
DRUG

0.5% TM

From D1 to D10, each subject will receive one drop of 0.5% timolol maleate ophthalmic gel forming solution each in the left and right eyes once daily at the same time every day under fasted condition.

Trial Locations (1)

313000

Huzhou Central Hospital, Huzhou

Sponsors
All Listed Sponsors
lead

Auson Pharmaceuticals Inc.

INDUSTRY